Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TmEGFR/IL13Rα2 01 CAR-T
i
Other names:
TmEGFR/IL13Rα2 01 CAR-T, IL13Rα2 CAR-T, Anti-EGFR/IL-13R alpha 2 CAR T cell therapy, Anti-Epidermal growth factor receptor/ Interleukin 13 Receptor subunit alpha 2 CAR-T therapy, CART-EGFR-IL13Ra2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Gilead, University of Pennsylvania
Drug class:
EGFR-targeted CAR-T immunotherapy, IL-13-targeted CAR-T immunotherapy
Related drugs:
‹
EGFR806-specific CAR T-cell therapy (1)
CART-EGFR (0)
CXCR5 Modified EGFR Targeted CAR-T Cells (0)
EGFR IL12 CART cells (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
SNC109 (0)
Undisclosed EGFR/B7H3 CAR-T (0)
MB-101 (0)
EGFR806-specific CAR T-cell therapy (1)
CART-EGFR (0)
CXCR5 Modified EGFR Targeted CAR-T Cells (0)
EGFR IL12 CART cells (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
SNC109 (0)
Undisclosed EGFR/B7H3 CAR-T (0)
MB-101 (0)
›
Associations
News
Trials
Filter by
Latest
over1year
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM (clinicaltrials.gov)
P1, N=18, Recruiting, University of Pennsylvania | Not yet recruiting --> Recruiting
over 1 year ago
Enrollment open
|
EGFR (Epidermal growth factor receptor)
|
EGFR amplification • EGFR wild-type • IDH wild-type
|
TmEGFR/IL13Rα2 01 CAR-T
2years
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM (clinicaltrials.gov)
P1, N=18, Not yet recruiting, University of Pennsylvania | Initiation date: Jun 2022 --> Mar 2023
2 years ago
Trial initiation date
|
EGFR (Epidermal growth factor receptor)
|
EGFR amplification • EGFR wild-type • IDH wild-type
|
cyclophosphamide • fludarabine IV • TmEGFR/IL13Rα2 01 CAR-T
almost3years
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM (clinicaltrials.gov)
P1, N=18, Not yet recruiting, University of Pennsylvania | Initiation date: Dec 2021 --> Jun 2022
almost 3 years ago
Clinical • Trial initiation date
|
EGFR (Epidermal growth factor receptor)
|
EGFR amplification • EGFR wild-type • IDH wild-type
|
cyclophosphamide • fludarabine IV • TmEGFR/IL13Rα2 01 CAR-T
almost3years
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM (clinicaltrials.gov)
P1, N=18, Not yet recruiting, University of Pennsylvania
almost 3 years ago
Clinical • New P1 trial
|
EGFR (Epidermal growth factor receptor)
|
EGFR amplification • EGFR wild-type • IDH wild-type
|
cyclophosphamide • fludarabine IV • TmEGFR/IL13Rα2 01 CAR-T
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login